Phibro Animal Health (PAHC) Misses Q2 EPS by 2c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks rally, crude prices fall
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
Phibro Animal Health Corporation Reports Third Quarter Results, Provides Revised Financial Guidance
May 4, 2022 4:25 PM EDTTEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (Nasdaq: PAHC) today announced financial results for its third quarter ended March 31, 2022.
Highlights for the three months ended March 31, 2022 (compared to the three months ended March 31, 2021) Net sales of $239.6 million, an increase of $27.9 million, or 13% Net income of $17.7 million, an increase of $5.5 million, or 45% Diluted EPS of $0.44, an increase of $0.14 or 47% Adjusted EBITDA of $28.0 million, comparable to the prior year Adjusted Net Income of $13.4 million, a decrease of $0.5 million, or... More